Callan Family Office’s Equinor EQNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$866K Sell
20,526
-2,907
-12% -$87.6K 0.02% 601
2025
Q4
$554K Sell
23,433
-4,823
-17% -$114K 0.01% 754
2025
Q3
$689K Buy
28,256
+2,061
+8% +$51.7K 0.02% 451
2025
Q2
$659K Buy
26,195
+16,840
+180% +$407K 0.02% 501
2025
Q1
$247K Sell
9,355
-11,136
-54% -$270K 0.02% 476
2024
Q4
$485K Buy
+20,491
New +$493K 0.03% 375
2024
Q1
Sell
-6,655
Closed -$211K 95
2023
Q4
$211K Hold
6,655
0.05% 97
2023
Q3
$218K Buy
+6,655
New +$206K 0.06% 82

Other funds holding EQNR

Callan Family Office's EQNR Position: Q1 2026 in Review

Callan Family Office reduced its Equinor (EQNR) stake by 12% in Q1 2026, selling an estimated $87.6K and leaving 20,526 shares worth $866K. The position accounts for 0.02% of the portfolio, ranked #601.

Callan Family Office first reported a position in EQNR in Q3 2023 and has held it in 8 quarters since. 415 funds tracked by Wall St. Rank hold EQNR as of Q1 2026.

  • Callan Family Office held 20,526 shares of Equinor worth $866K as of Q1 2026.
  • Callan Family Office sold 2,907 Equinor shares in Q1 2026, an estimated $87.6K.
  • Equinor made up 0.02% of Callan Family Office's portfolio in Q1 2026, its #601 holding.
  • Callan Family Office first reported a position in Equinor in Q3 2023 and has held it in 8 quarters since.
  • 415 funds tracked by Wall St. Rank held Equinor as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.